Acta paediatrica (Oslo, Norway : 1992) · 2025
Alarming Global Rise in Adolescent Metabolic Dysfunction-Associated Steatotic Liver Disease by 2030.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Xiang, Yu Hua
Аннотация
AIM: This study forecasts the global burden of ultrasound-diagnosed MASLD in adolescents (15-19 years) from 2020 to 2030, examining socioeconomic influences.
METHODS: Using generalised additive models (GAM) and estimated annual percentage change (EAPC), age-standardised incidence (ASIR), mortality (ASDR) and disability-adjusted life years (DALYs) rates were projected. Regional analyses used the Socio-Demographic Index (SDI), with regression models quantifying associations.
RESULTS: Global ASIR is projected to rise significantly (EAPC: +1.46%), outpacing slower increases in DALYs (EAPC: +0.20%) and ASDR (EAPC: +0.18%). High-income North America faces the steepest ASIR surge (EAPC: +2.52%), while Central/Eastern Europe and Central Asia are stable. By 2030, low-SDI regions will have the highest median ASIR, with Turkmenistan predicted to have the world's highest (0.77 per 100 000). Striking disparities exist: higher SDI strongly correlates with elevated ASIR in Europe (R2 = 0.339), indicating lifestyle risks in affluent settings. Conversely, higher SDI correlates with reduced DALYs/ASDR elsewhere. Despite some declines in low-SDI areas, high-income North America and vulnerable low-SDI regions (e.g., Turkmenistan) face escalating burdens.
CONCLUSIONS: Socioeconomic factors and lifestyle disparities drive divergent global adolescent MASLD trajectories. Without intervention, the burden will surge by 2030-particularly in high-income North America and low-SDI hotspots-demanding region-specific policies to address metabolic health inequities.
METHODS: Using generalised additive models (GAM) and estimated annual percentage change (EAPC), age-standardised incidence (ASIR), mortality (ASDR) and disability-adjusted life years (DALYs) rates were projected. Regional analyses used the Socio-Demographic Index (SDI), with regression models quantifying associations.
RESULTS: Global ASIR is projected to rise significantly (EAPC: +1.46%), outpacing slower increases in DALYs (EAPC: +0.20%) and ASDR (EAPC: +0.18%). High-income North America faces the steepest ASIR surge (EAPC: +2.52%), while Central/Eastern Europe and Central Asia are stable. By 2030, low-SDI regions will have the highest median ASIR, with Turkmenistan predicted to have the world's highest (0.77 per 100 000). Striking disparities exist: higher SDI strongly correlates with elevated ASIR in Europe (R2 = 0.339), indicating lifestyle risks in affluent settings. Conversely, higher SDI correlates with reduced DALYs/ASDR elsewhere. Despite some declines in low-SDI areas, high-income North America and vulnerable low-SDI regions (e.g., Turkmenistan) face escalating burdens.
CONCLUSIONS: Socioeconomic factors and lifestyle disparities drive divergent global adolescent MASLD trajectories. Without intervention, the burden will surge by 2030-particularly in high-income North America and low-SDI hotspots-demanding region-specific policies to address metabolic health inequities.